Literature DB >> 352252

Pharmacokinetics of aminoglycosides in subjects with normal and impaired renal function.

A Leroy, G Humbert, G Oksenhendler, J P Fillastre.   

Abstract

Since aminoglycosides are antibiotics almost exclusively eliminated by the kidneys, their pharmacokinetic study in normal subjects and in uraemic patients is essential to establish dosage schedules adapted to various degrees of renal impairment. Many studies have been recently reported, particularly with regard to the newly developed desoxystreptamine aminoglycoside antibiotics. The present paper is a compilation of our own results and a review of the literature concerning Streptomycin, Kanamycin and its semi-synthetic derivation, Amikacin or BB-K8, Gentamicin, Tobramycin, Lividomycin, Sisomicin and its semi-synthetic derivation, Netilmicin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 352252     DOI: 10.1159/000401061

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN: 0066-4758


  9 in total

1.  Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus.

Authors:  Jin Lee; Nicole Ammerman; Anusha Agarwal; Maram Naji; Si-Yang Li; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

3.  Pharmacokinetics of streptomycin with particular reference to its distribution in plasma, milk and uterine fluid of she-buffaloes.

Authors:  C Jayachandran; M K Singh; S D Singh; N C Banerjee
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

4.  The disposition kinetics, urinary excretion and dosage regimen of amikacin in cross-bred bovine calves.

Authors:  S P Saini; A K Srivastava
Journal:  Vet Res Commun       Date:  1998-01       Impact factor: 2.459

5.  Pharmacokinetics of habekacin in patients with renal insufficiency.

Authors:  J P Fillastre; A Leroy; G Humbert; B Moulin; P Bernadet; S Josse
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients.

Authors:  E Sultan; C Richard; M Pezzano; P Auzepy; E Singlas
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Gentamicin pharmacokinetic changes in induced acute canine nephrotoxic glomerulonephritis.

Authors:  J E Riviere; G L Coppoc; E J Hinsman; W W Carlton
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

8.  Accidental amikacin overdose in man: emergency therapy by extrarenal dialysis.

Authors:  J P Flandrois; P Bouletreau; C Auboyer; R Ducluzeau; R Muchada; J Etienne
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 9.  Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment.

Authors:  Luiz Vicente Ribeiro Ferreira da Silva Filho; Flavia de Aguiar Ferreira; Francisco José Caldeira Reis; Murilo Carlos Amorim de Britto; Carlos Emilio Levy; Otavio Clark; José Dirceu Ribeiro
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.